SaNOtize Nasal Spray is the Advent of End of Coronavirus?
The trials claim that SaNOtize’s nasal spray represents a safe and powerful antiviral treatment that could prevent the transmission of the pathogen
A self-administered nitric oxide nasal spray (NONS) developed by Vancouver-based biotech firm SaNOtize has been found to reduce coronavirus effects in infected patients.
The results have been compiled after the completion of early-stage clinical trials in Canada and the United Kingdom (UK).
The trials claim that SaNOtize’s nasal spray represents a safe and powerful antiviral treatment that could prevent the transmission of the pathogen.
Read Also
Will Vaccine Dearth in India Have a Global Impact?
The researchers said NONS culls the virus in the upper airways, preventing it from incubating and making its way to the lungs.
